Melanocytes in melanocytic naevi and melanomas can display great variation. The presence of nuclear pseudoinclusions (NPI) is said to be useful in the histological and cytological differential diagnosis of malignant melanoma. The prevalence and characteristics of NPI in a series of 493 naevi and 50 melanomas are described. NPI were found in 31% of adult naevi, 30% of congenital naevi from children, 42% of Spitz naevi, 20% of dysplastic naevi, and 56% of melanomas. The presence of NPI is not a reliable criterion for differentiating melanoma from benign melanocytic lesions, although it is useful in distinguishing melanocytic from non-melanocytic tumours. (J7 Clin Pathol 1995;48:676-677) Keywords: Melanocytic naevi, pseudoinclusions, melanoma.
The presence of nuclear pseudoinclusions (NPI) is a sufficiently common and consistent' feature of malignant melanomas to attain the status of a "characteristic". The current study found NPI in 56% of 50 malignant melanomas, but also in 31% of benign melanocytic lesions. In practice the diagnosis of malignant melanoma requires a constellation of histological features in which the presence of NPI is a minor criterion.23 Although NPI may be of value for separating malignant melanomas from other tumours,4 NPI do not distinguish melanoma from melanoma simulants or from common acquired naevi. For each lesion, a single cross-section (4 gtm thick) was examined. NPI were defined as wholly intranuclear inclusions which occupied more than half of the cross-sectional nuclear area, had a well defined smooth rim, and contained material similar to that of the cytoplasm. Cells with multivesicular nuclei were not included. To determine whether NPI were associated with specific cytoarchitectural patterns, the presence of melanin and the type, location and numbers of cells with pigmented NPI were noted.
Results Naevi (figure) and melanomas contained NPI ( Despite the stress laid on NPI in melanomas, NPI in naevi are not likely to cause overdiagnosis of malignancy. Firstly, most difficulties occur in interpretation of superficial lesions (junctional, compound, or dysplastic naevi and superficial spreading melanoma). These are the lesions that are least likely to contain NPI, which are usually found in IDN and nodular malignant melanoma. Thus, NPI are largely absent from the lesions in which they would be most confusing. The Spitz naevus, cellular blue naevus and the deep penetrating naevus are exceptions to this rule, as, in addition to the finding of NPI in 42% of Spitz naevi in the current study, they have been described previously in Spitz naevi24 and in a deep penetrating naevus.'0 Secondly, the differential diagnosis of malignant melanoma relies on a combination of clinical, architectural and cytological criteria, and, in practice, NPI are relegated to a minor role. In cytology architectural features are lost, so cytological features such as nuclear morphology become more important. However, clinicians are unlikely to aspirate benign naevi, and whilst axillary lymph node capsular naevus cell rests can show NPI (illustrated but not discussed in 11) they are too rare to cause confusion, especially in the absence of other cytological criteria of malignancy.
In conclusion, experienced pathologists will not make misdiagnoses of melanocytic lesions on the basis ofNPI, but their presence in benign lesions has received little attention. They are found in melanoma simulants such as dysplastic, Spitz and cellular blue naevi, as well as in obviously benign congenital and common acquired melanocytic naevi.
